New hope for advanced cancers: SNV1521 enters human trials
NCT ID NCT06220864
First seen Apr 18, 2026 · Last updated May 08, 2026 · Updated 6 times
Summary
This early-stage study tests a new medicine called SNV1521 in people with advanced solid tumors that have spread or cannot be removed. The main goals are to check if the drug is safe, tolerable, and to find the best dose. About 400 participants will receive different doses, and some may also get other cancer treatments alongside SNV1521.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Arthur J.E. Child Comprehensive Cancer Centre
RECRUITINGCalgary, Alberta, T2N 5G2, Canada
-
Gustave Roussy
RECRUITINGVillejuif, 94805, France
-
Institut Bergonie
RECRUITINGBordeaux, 33076, France
-
Istituto Clinico Humanitas
RECRUITINGMilan, 20089, Italy
-
Istituto Europeo di Oncologia (IEO) (European Institute of Oncology)
RECRUITINGMilan, 20141, Italy
-
Linear Clinical Research
RECRUITINGCrawley, Western Australia, 6009, Australia
-
Monash Health
RECRUITINGClayton, Victoria, 3168, Australia
-
NEXT Oncology - Barcelona
RECRUITINGBarcelona, 08023, Spain
-
NEXT Oncology - Hospital Quironsalud Madrid
RECRUITINGMadrid, 28223, Spain
-
Princess Alexandra Hospital
RECRUITINGWoolloongabba, Queensland, 4102, Australia
-
Princess Margaret Hospital
RECRUITINGToronto, Ontario, M5G 2M9, Canada
-
START Center for Cancer Care
RECRUITINGWest Valley City, Utah, 84119, United States
-
Sarah Cannon Research Institute
RECRUITINGNashville, Tennessee, 37203, United States
-
Scientia Clinical Research
RECRUITINGRandwick, New South Wales, 2031, Australia
-
Smilow Cancer Hospital at Yale New Haven
RECRUITINGNew Haven, Connecticut, 06511, United States
-
The Alfred Hospital
RECRUITINGMelbourne, Victoria, 3004, Australia
-
The START Center for Cancer Care - Madrid - CIOCC - Hospital Universitario Madrid Sanchinarro
RECRUITINGMadrid, 28050, Spain
-
The University of Texas M.D. Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
-
Thomas Jefferson University
RECRUITINGPhiladelphia, Pennsylvania, 19144, United States
-
UNICANCER - Centre Leon-Berard (CLB)
RECRUITINGLyon, 69008, France
-
Vall d'Hebron University Hospital
RECRUITINGBarcelona, 08035, Spain
Conditions
Explore the condition pages connected to this study.